MBR Charleston is a purpose-built, 7,000-square-foot research site in North Charleston, South Carolina, and the network’s foremost respiratory site. The site pairs strong internal medicine depth with experienced investigator leadership, specialized research staff, and a patient-focused approach to complex protocol execution.
Led by Gregory Feldman, MD, CPI, the site is especially fit for respiratory, infectious disease, vaccine, and general internal medicine studies, with fast startup processes and community-based recruitment strength.
MBR Charleston is backed by centralized contracting, startup, regulatory, and participant recruitment teams — a unified operations model that brings continuity across the MBR network.